31
Participants
Start Date
March 31, 2007
Primary Completion Date
August 31, 2009
Study Completion Date
November 30, 2009
N-acetylcysteine
Capsules available in 300 mg or 600mg strength. Target dose of n-acetylcysteine will be 60mg/kg/day TID. Dosage will be increased to this target dose from week 1 to week 3 barring side effects. Dose reduction will be allowed at any time for adverse side effects. Maximum dose of n-acetylcysteine will be 4200mg/day.
Placebo
Subjects randomized to placebo arm will receive placebo pill for duration of study.
Riley Hospital, Riley Child and Adolescent Psychiatry Clinic, Indianapolis
National Alliance for Autism Research
OTHER
Indiana University School of Medicine
OTHER